Moolec Science (MLEC) EBITDA (2022 - 2024)
Moolec Science's (MLEC) quarterly EBITDA came in at $2.3 million in Q4 2024, down 14.71% year-on-year from $2.7 million in Q1 2024, and up 261.49% quarter-over-quarter from -$1.4 million in Q3 2024.
Moolec Science (MLEC) EBITDA (2022 - 2024) Analysis & Trends
Moolec Science has disclosed EBITDA across 3 years of filings, most recently posting $2.3 million for Q4 2024.
- EBITDA for Q4 2024 came in at $2.3 million, down 14.71% year-over-year; the trailing twelve-month figure through Dec 2024 was -$28.4 million (down 128.31% YoY), and the FY2024 annual result was -$30.2 million, down 159.42% from the prior year.
- EBITDA came in at $2.3 million for Q4 2024 at Moolec Science, up from -$1.4 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $99.8 million in Q2 2023 to a low of -$30.2 million in Q2 2024.
- The 3-year median for EBITDA is $784455.5 (2022), against an average of $10.1 million.
- Peak annual rise in EBITDA reached 22493.33% in 2023, while the deepest fall reached 324.79% in 2023.
- Moolec Science's EBITDA stood at $48.0 million in 2022, then sank by 94.44% to $2.7 million in 2023, then fell by 14.71% to $2.3 million in 2024.
- The last three EBITDA figures came in at $2.3 million (Q4 2024), -$1.4 million (Q3 2024), and -$30.2 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -65.83 Mn |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.27 Mn |
| Sep 30, 2024 | -1.41 Mn |
| Jun 30, 2024 | -30.15 Mn |
| Mar 31, 2024 | 847,485.00 |
| Dec 31, 2023 | 2.67 Mn |
| Sep 30, 2023 | -1.62 Mn |
| Jun 30, 2023 | 99.78 Mn |
| Mar 31, 2023 | -358,578.00 |
| Dec 31, 2022 | 47.96 Mn |
| Sep 30, 2022 | 721,426.00 |
| Jun 30, 2022 | -445,598.00 |
| Mar 31, 2022 | 1.17 Mn |